Smart Materials

Keywords:
development of synthetic receptors, molecularly imprinted and conjugated polymers, computational design, nanotechnology, molecular recognition, drug development, membrane technology, sensor technology

Abstract:
The Smart Materials Group in Cranfield Health is one of the Word Leaders in Molecular Imprinting specialising in the development of world class polymer science for solving practical problems in separation and sensing. To date over 100 publications, 20 patents and a wide portfolio of high value academic and industrial projects has resulted from their continuing research in areas such as: • development of synthetic receptors • molecularly imprinted and conjugated polymers • computational design • nanotechnology • molecular recognition • drug development • membrane technology • sensor technology Examples of notable projects will be described which have been funded by industry (GlaxoSmithKline, Sphere Medical, Pelican Technologies and Biosensia) and funding organisations such the EU, Marie Curie, NOAA and DTI. The application of this research is far reaching and has/will impact on areas such as; (a) medical/clinical diagnostics in assays and sensors, (b) toxicity screening, (c) development of new pharmaceuticals and drug cocktails, (d) new sensors for pharmaceutical manufacturing, (e) implantable sensors and ''smart'' pills and (f) nanotechnology.

Back to Program

Nanotech 2007 Conference Program Abstract